Instagram CEO denies addiction claims in landmark US trial
“I’ve never claimed being able to diagnose addiction clinically,” Mosseri responded during the exchange. “I’m sure I was…
Meta, Google face jury in landmark US addiction trial
He contended the A was for addicting, the B for brains and the C for children. “They don’t…
Auckland developer Andrew Montgomerie testifies at his wounding trial
Montgomerie, 58, has been on trial since last week, accused of wounding with reckless disregard for the safety…
Andrew Montgomerie glass attack trial: Witness at Westmere, Auckland mansion contradicts developer’s account
She then voiced similar sentiments to the person she had been chatting with. “I think Mont just hit…
AI helped spot breast cancers earlier, was linked to fewer dangerous cases emerging between screenings
Earlier results from the same project showed the technology can increase cancer detection while reducing the workload for…
The power station in your driveway: Queenstown trial uses EVs to power households
“Cars store a lot of energy. When that’s in a petrol tank, it’s not good for much else…
Jury returns verdict in trial over Whangamatā bakery owner’s collision with pedestrian
Brett Henderson got in her Isuzu D-Max ute, and drove to find the man – Duane Jackison –…
Juror dismissed at Auckland property developer Andrew Montgomerie’s wounding trial
The complainant, who cannot yet be identified due to a pending request for permanent name suppression, has said…
Sydney hit‑and‑run case over death of NZ lawyer Mitch East ends after accused driver dies before trial
The criminal matter experienced months-long delays, with Kokotatsios eventually pleading not guilty to charges of dangerous driving occasioning…
Auckland property developer Andrew Montgomerie on trial over wounding of Westmere partygoer
He said he had taken a “very small amount” of the drug and was on his second glass…
Amber Heard claims she has lost her ‘ability to speak’ after Depp trial
Bang Showbiz 26 Jan, 2026 05:49 AM3 mins to read Subscribe to listenAccess to Herald Premium articles require…
Moderna mRNA-based drug cut the risk of recurrence or death when combined with immunotherapy Keytruda
“Today’s results highlight the potential of a prolonged benefit of the intismeran autogene and Keytruda combination,” Kyle Holen,…